Decentralised Clinical Trials in Europe: Lessons from a Pandemic
Author: Graham Belgrave, SVP of European Operations at Advanced Clinical
Since the onset of the COVID-19 pandemic, DCTs have been critical to advancing clinical research by minimising in-person interactions. Benefits include the potential to improve recruitment, facilitate data collection, and reduce the need for travel by patients and CRAs alike, resulting in efficiencies and continued profitability. DCTs demand new roles and partnerships which will likely continue long after the pandemic comes under control. Read our feature article in the Journal of Clinical Studies to learn more.